Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Vanguard Global ex-US Real Estate Index Fd ETF (VNQI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.39 (market cap $2.27B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $42.04 (market cap $3.80B). The key difference: Vanguard Global ex-US Real Estate Index Fd ETF is the larger of the two by market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Vanguard Global ex-US Real Estate Index Fd ETF nearer its low. Which is the better fit depends on your goals.
| SLS | VNQI | |
|---|---|---|
Market Cap | $2.27B | $3.80B |
Volume | 4,179,659 | 277,049 |
Sector | Health | — |
52-Week High | $15.46 | $50.76 |
52-Week Low | $1.39 | $41.81 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 95 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VNQI trades at $42.06, up 0.6% with a bearish technical signal from moving averages. The ETF focuses on international real estate across 30+ countries, offering diversification but facing recent price pressure below key moving averages. Short interest declined 45.9% in September (Defense World, 2026-10-02), potentially indicating reduced bearish sentiment despite the technical downtrend.
The outlook remains cautious given bearish technicals and international real estate exposure risks. Competitive advantages include lower expense ratios (0.12%) and higher dividend yields versus peers. Key risks involve global economic sensitivity and currency fluctuations affecting international holdings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Vanguard Global ex-US Real Estate Index Fd ETF
The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →
